Verrica Pharmaceuticals Inc. (VRCA) · INSIDERData sourcesSEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago
Public companyVerrica Pharmaceuticals Inc.
VRCACIK 0001660334
Price$3.19
1 year-7.5%
Disclosed transactions11
Buys / sells7 / 0
Max Insider Score52
Connections with evidence5
VRCA · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 38 | ZDZawitz DavidChief Operating Officer | VRCAVerrica Pharmaceuticals Inc. Open-market purchase | BUY | $30K 6,000 sh | Aug 17, 2026 | Aug 18, 2026 |
| 30 | RJRieger JaysonDirector, CEO and President | VRCAVerrica Pharmaceuticals Inc. Open-market purchase | BUY | $25K 5,000 sh | Aug 17, 2026 | Aug 18, 2026 traded Aug 17, 2026 | +1d | SEC Form 4 | |
| 37 | RJRieger JaysonDirector, CEO and President | VRCAVerrica Pharmaceuticals Inc. Open-market purchase | BUY | $101K 20.0K sh | Aug 14, 2026 | Aug 18, 2026 traded Aug 14, 2026 | +4d | SEC Form 4 | |
| 9 | | VRCAVerrica Pharmaceuticals Inc. Grant or award | A | — 16.0K sh | Jun 5, 2026 | Jun 9, 2026 traded Jun 5, 2026 | +4d | SEC Form 4 | |
| 9 | ELEichenfield LawrenceDirector | VRCAVerrica Pharmaceuticals Inc. Grant or award | A | — 16.0K sh | Jun 5, 2026 | Jun 9, 2026 traded Jun 5, 2026 | +4d | SEC Form 4 | |
| 5 | ZDZawitz DavidChief Operating Officer | VRCAVerrica Pharmaceuticals Inc. Grant or award | A | — 171.3K sh | Jun 5, 2026 | Jun 9, 2026 traded Jun 5, 2026 | +4d | SEC Form 4 | |
| 5 | RJRieger JaysonDirector, CEO and President | VRCAVerrica Pharmaceuticals Inc. Grant or award | A | — 512.3K sh | Jun 5, 2026 | Jun 9, 2026 traded Jun 5, 2026 | +4d | SEC Form 4 | |
| 46 | RJRieger JaysonDirector, CEO and President | VRCAVerrica Pharmaceuticals Inc. Open-market purchase | BUY | — 23.6K sh | Nov 25, 2025 | Nov 25, 2025 traded Nov 25, 2025 | +0d | SEC Form 4 | |
| 46 | ZDZawitz DavidChief Operating Officer | VRCAVerrica Pharmaceuticals Inc. Open-market purchase | BUY | $42K 10.0K sh | Nov 25, 2025 | Nov 25, 2025 traded Nov 25, 2025 | +0d | SEC Form 4 | |
| 52 | RJRieger JaysonDirector, CEO and President | VRCAVerrica Pharmaceuticals Inc. Open-market purchase | BUY | $400K 94.3K sh | Nov 25, 2025 | Nov 25, 2025 traded Nov 25, 2025 | +0d | SEC Form 4 | |
| 46 | ZDZawitz DavidChief Operating Officer | VRCAVerrica Pharmaceuticals Inc. Open-market purchase | BUY | — 2,500 sh | Nov 25, 2025 | Nov 25, 2025 traded Nov 25, 2025 | +0d | SEC Form 4 | |
Director, CEO and President · Nov 25, 2025